France Bed Lowers Full-Year Profit Outlook Despite Modest Sales Growth

The latest update is out from France Bed Holdings Co., Ltd. ( (JP:7840) ).

France Bed Holdings reported consolidated net sales of ¥44.8 billion for the nine months ended December 31, 2025, up 1.4% year on year, but operating profit fell 5.5% to ¥3.09 billion and profit attributable to owners of parent declined 10.7% to ¥1.86 billion. Despite softer earnings, the equity ratio improved to 58.5% as total assets decreased, and the company maintained its dividend stance, projecting a slight increase in the full-year dividend to ¥41 per share while revising down full-year profit forecasts, signaling pressure on profitability even as revenues grow modestly.

For the full fiscal year ending March 31, 2026, the company now expects net sales of ¥61.5 billion, up 1.5% year on year, but forecasts operating and ordinary profit to fall by around 10% and profit attributable to owners of parent to drop 10% to ¥2.65 billion. The downward revision of earnings guidance and partial withdrawal of its medium-term management plan underscore a more challenging operating environment and may temper investor expectations, even as stable dividends provide some support to shareholders.

The most recent analyst rating on (JP:7840) stock is a Buy with a Yen1473.00 price target. To see the full list of analyst forecasts on France Bed Holdings Co., Ltd. stock, see the JP:7840 Stock Forecast page.

More about France Bed Holdings Co., Ltd.

France Bed Holdings Co., Ltd. is a Japan-based manufacturer and distributor of beds, bedding, and related healthcare and welfare equipment, listed on the Tokyo Stock Exchange. The group focuses on the domestic consumer and medical/nursing care markets, supplying products and services that support sleep, daily living, and elderly care needs across Japan.

Average Trading Volume: 41,128

Technical Sentiment Signal: Buy

Current Market Cap: Yen47.03B

Learn more about 7840 stock on TipRanks’ Stock Analysis page.